Advisor Group Holdings, Inc. Axonics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,633 shares of AXNX stock, worth $115,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,633
Previous 1,811
9.83%
Holding current value
$115,910
Previous $126,000
8.73%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AXNX
# of Institutions
100Shares Held
21.6MCall Options Held
82KPut Options Held
65.3K-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Westchester Capital Management, LLC Valhalla, NY1.45MShares$103 Million4.89% of portfolio
-
Mackenzie Financial Corp Toronto Ontario, A61.25MShares$88.9 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$84.1 Million0.0% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.05MShares$74.5 Million1.56% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...